Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Inkook Chun"'
Autor:
Marco Ruella, Yong Gu Lee, Nicholas Yang, Inkook Chun, Patrizia Porazzi, Alberto Carturan, Luca Paruzzo, Christopher Tor Sauter, Puneeth Guruprasad, Raymone Pajarillo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 4 (2023)
Immunotherapy has revolutionized the treatment of cancer. In particular, immune checkpoint blockade, bispecific antibodies, and adoptive T-cell transfer have yielded unprecedented clinical results in hematological malignancies and solid cancers. Whil
Externí odkaz:
https://doaj.org/article/3234ef3ae87941f2a4475be752f10e55
Publikováno v:
Journal of The Korean Association of Regional Geographers. 28:170-182
Autor:
Marco Ruella, Patrizia Porazzi, Stephen J. Schuster, James Gerson, Sara Cherry, David C. Schultz, Kanupriya Whig, Yunlin Zhang, Xueqing Maggie Lu, Simon F. Lacey, Wan-Jung Chang, Joseph A. Fraietta, Sarah E. Church, Khrystyna North, Elise A. Chong, Saar Gill, Jakub Svoboda, Katherine D. Cummins, Kimberly V. Amelsberg, Nicholas Yang, Inkook Chun, Seok Jae Hong, Hatcher J. Ballard, Ruchi Patel, Christopher Tor Sauter, Raymone Pajarillo, Guido Ghilardi, Puneeth Guruprasad, Yong Gu Lee
Supplementary Figure from Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d63f43f4903bc7d8bbd7a04cf8ac881
https://doi.org/10.1158/2159-8290.22541380.v1
https://doi.org/10.1158/2159-8290.22541380.v1
Autor:
Marco Ruella, Patrizia Porazzi, Stephen J. Schuster, James Gerson, Sara Cherry, David C. Schultz, Kanupriya Whig, Yunlin Zhang, Xueqing Maggie Lu, Simon F. Lacey, Wan-Jung Chang, Joseph A. Fraietta, Sarah E. Church, Khrystyna North, Elise A. Chong, Saar Gill, Jakub Svoboda, Katherine D. Cummins, Kimberly V. Amelsberg, Nicholas Yang, Inkook Chun, Seok Jae Hong, Hatcher J. Ballard, Ruchi Patel, Christopher Tor Sauter, Raymone Pajarillo, Guido Ghilardi, Puneeth Guruprasad, Yong Gu Lee
Chimeric antigen receptor T-cell (CART) immunotherapy led to unprecedented responses in patients with refractory/relapsed B-cell non-Hodgkin lymphoma (NHL); nevertheless, two thirds of patients experience treatment failure. Resistance to apoptosis is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36b0483ba6841122a031e009f0d25306
https://doi.org/10.1158/2159-8290.c.6549622.v1
https://doi.org/10.1158/2159-8290.c.6549622.v1
Autor:
Yong Gu Lee, Puneeth Guruprasad, Guido Ghilardi, Raymone Pajarillo, Christopher Tor Sauter, Ruchi Patel, Hatcher J. Ballard, Seok Jae Hong, Inkook Chun, Nicholas Yang, Kimberly V. Amelsberg, Katherine D. Cummins, Jakub Svoboda, Saar Gill, Elise A. Chong, Khrystyna North, Sarah E. Church, Joseph A. Fraietta, Wan-Jung Chang, Simon F. Lacey, Xueqing Maggie Lu, Yunlin Zhang, Kanupriya Whig, David C. Schultz, Sara Cherry, James Gerson, Stephen J. Schuster, Patrizia Porazzi, Marco Ruella
Publikováno v:
Cancer Discov
Chimeric antigen receptor T-cell (CART) immunotherapy led to unprecedented responses in patients with refractory/relapsed B-cell non-Hodgkin lymphoma (NHL); nevertheless, two thirds of patients experience treatment failure. Resistance to apoptosis is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d3478631319580234e2784ba61fc01d
https://europepmc.org/articles/PMC9547936/
https://europepmc.org/articles/PMC9547936/
Autor:
Yong Gu Lee, Nicholas Yang, Inkook Chun, Patrizia Porazzi, Alberto Carturan, Luca Paruzzo, Christopher Tor Sauter, Puneeth Guruprasad, Raymone Pajarillo, Marco Ruella
Publikováno v:
Journal for ImmunoTherapy of Cancer. 11:e005967
Immunotherapy has revolutionized the treatment of cancer. In particular, immune checkpoint blockade, bispecific antibodies, and adoptive T-cell transfer have yielded unprecedented clinical results in hematological malignancies and solid cancers. Whil
Autor:
Olga Shestova, Maria Wysocka, Hatcher J. Ballard, Yi-Hao Chiang, Daniel J. Powell, Mohamed Abdel-Mohsen, Carl H. June, Wei Xie, Raymone Pajarillo, David M. Barrett, Seok Jae Hong, Stephen J. Schuster, Inkook Chun, Saar Gill, Ki-Hyun Kim, Antonia Rotolo, Alain H. Rook, Avery D. Posey, Stefan K. Barta, Marco Ruella, Yong Gu Gu Lee
Publikováno v:
Blood. 136:51-52
Chimeric Antigen Receptor T cells (CART) have led to unprecedented clinical responses in relapsed or refractory (r/r) B-cell acute lymphoblastic leukemia (B-ALL), non-Hodgkin lymphomas (NHL), and multiple myeloma. However, despite these exciting resu
Autor:
Olga Shestova, Simon F. Lacey, Brian Granda, Jessica Perazzelli, Stephan A. Grupp, Pranali Ravikumar, Katherine D. Cummins, Liaomin Peng, Yong Gu Lee, Nathan Singh, Ting Liu, Marco Ruella, Mohamed Abdel-Mohsen, Noelle V. Frey, David M. Barrett, Florent Colomb, Saar Gill, Steven Highfill, Carl H. June, Janis K. Burkhardt, Raymone Pajarillo, Shannon L. Maude, Amy Shyu, Jennifer Brogdon, Boris Engels, Melissa Ramones, Mohammad Damra, Dongfang Liu, David A. Christian, Daron M. Standley, Andrew Price, Inkook Chun, Xueqing Maggie Lu, Regina M. Young, Linlin Zhao, Nathan H. Roy
Publikováno v:
Nature medicine. 27(5)
While CD19-directed chimeric antigen receptor (CAR) T cells can induce remission in patients with B cell acute lymphoblastic leukemia (ALL), a large subset relapse with CD19- disease. Like CD19, CD22 is broadly expressed by B-lineage cells and thus s